PHASE II TRIAL OF DOCETAXEL (D), CISPLATIN (C) AND FLUOROURACIL (F), FOLLOWED BY RADIOTHERAPY (XRT) AND CARBOPLATIN (CBDCA) IN PATIENTS (PTS) WITH UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles